• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

便携式空气抽吸器经鼻旁空气抽吸治疗急性偏头痛的疗效:一项随机、双盲研究。

Effectiveness of paranasal air suction on acute migraine using portable air sucker - a randomized, double blind study.

机构信息

Neurology Unit, Teaching Hospital Kandy, Kandy, Sri Lanka.

University of Peradeniya, Peradeniya, Sri Lanka.

出版信息

BMC Neurol. 2021 Apr 24;21(1):176. doi: 10.1186/s12883-021-02203-x.

DOI:10.1186/s12883-021-02203-x
PMID:33892652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8066867/
Abstract

BACKGROUND

Migraine is a primary headache disorder and is the most common disabling primary headache disorder that occurs in children and adolescents. A recent study showed that paranasal air suction can provide relief to migraine headache. However, in order to get the maximum benefit out of it, an easy to use effective air sucker should be available. Aiming to fulfil the above requirement, a randomized, double blind control clinical trial was conducted to investigate the efficacy of a recently developed low-pressure portable air sucker.

METHODS

Eighty-six Sri Lankan school children of age 16-19 years with migraine were enrolled for the study. They were randomly allocated into two groups, and one group was subjected to six intermittent ten-second paranasal air suctions using the portable air sucker for 120 s. The other group was subjected to placebo air suction (no paranasal air suction). The effect of suction using portable air sucker was the primary objective but side of headache, type of headache, and gender were also studied as source variables. The primary response studied was severity of headache. In addition, left and right supraorbital tenderness, photophobia, phonophobia, numbness over the face and scalp, nausea and generalized tiredness/weakness of the body were studied. The measurements on all those variables were made before and after suction, and the statistical analysis was performed based on before and after differences. As a follow-up, patients were monitored for 24-h period.

RESULTS

There was a significant reduction in the severity of headache pain (OR = 25.98, P < 0.0001), which was the primary outcome variable, and other migraine symptoms studied, tenderness (left) (OR = 289.69, P < 0.0001), tenderness (right) (OR > 267.17, P < 0.0001), photophobia (OR = 2115.6, P < 0.0001), phonophobia (OR > 12.62, P < 0.0001) nausea (OR > 515.59, P < 0.0001) and weakness (OR = 549.06, P < 0.0001) except for numbness (OR = 0.747, P = 0.67) in the treatment group compared to the control group 2 min after the suction. These symptoms did not recur within 24-h period and there were no significant side effects recorded during the 24-h observation period.

CONCLUSION

This pilot study showed that low-pressure portable air sucker is effective in paranasal air suction, and suction for 120 s using the sucker can provide an immediate relief which can last for more than 24-h period without any side effects.

TRAIL REGISTRATION

Clinical Trial Government Identification Number - 1548/2016. Ethical Clearance Granted Institute - Medical Research Institute, Colombo, Sri Lanka (No 38/2016). Sri Lanka Clinical Trial Registration No: SLCTR/2017/018 . Date of registration = 29/ 06/2017. Approval Granting Organization to use the device in the clinical trial- National Medicines Regulatory Authority Sri Lanka (16 Jan 2018), The device won award at Geneva international inventers exhibition in 2016 and President award in 2018 in Sri Lanka. It is a patented device in Sri Lanka and patent number was SLKP/1/18295. All methods were carried out in accordance with CONSORT 2010 guidelines.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5816/8066867/33e7920b69ae/12883_2021_2203_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5816/8066867/52d6fc52fedf/12883_2021_2203_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5816/8066867/33e7920b69ae/12883_2021_2203_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5816/8066867/52d6fc52fedf/12883_2021_2203_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5816/8066867/33e7920b69ae/12883_2021_2203_Fig2_HTML.jpg
摘要

背景

偏头痛是一种原发性头痛障碍,是儿童和青少年最常见的致残性原发性头痛障碍。最近的一项研究表明,鼻窦空气抽吸可以缓解偏头痛。然而,为了最大限度地受益,应该有一种易于使用且有效的空气抽吸器。为了满足上述要求,进行了一项随机、双盲对照临床试验,以研究最近开发的低压便携式空气抽吸器的疗效。

方法

86 名年龄在 16-19 岁的斯里兰卡在校儿童患有偏头痛,他们被纳入研究。他们被随机分为两组,一组接受六次间歇性十秒钟的鼻窦空气抽吸,使用便携式空气抽吸器抽吸 120 秒。另一组接受安慰剂空气抽吸(无鼻窦空气抽吸)。使用便携式空气抽吸器的效果是主要的观察目标,但头痛的侧别、头痛的类型和性别也作为源变量进行了研究。主要的反应研究是头痛的严重程度。此外,还研究了左、右眶上压痛、畏光、畏声、面部和头皮麻木、恶心和全身疲劳/无力。所有这些变量的测量值在抽吸前后进行,基于前后差异进行了统计分析。作为随访,对患者进行了 24 小时监测。

结果

头痛疼痛严重程度(OR=25.98,P<0.0001)显著降低,这是主要的观察结果,其他研究的偏头痛症状,如压痛(左)(OR=289.69,P<0.0001)、压痛(右)(OR>267.17,P<0.0001)、畏光(OR=2115.6,P<0.0001)、畏声(OR>12.62,P<0.0001)、恶心(OR>515.59,P<0.0001)和乏力(OR=549.06,P<0.0001),除了麻木(OR=0.747,P=0.67),在治疗组中,与对照组相比,在抽吸后 2 分钟内有明显的改善。这些症状在 24 小时内没有复发,在 24 小时观察期间没有记录到任何明显的副作用。

结论

这项初步研究表明,低压便携式空气抽吸器在鼻窦空气抽吸中是有效的,使用抽吸器抽吸 120 秒可以立即缓解头痛,缓解效果可持续超过 24 小时,且无副作用。

临床试验注册

临床研究政府识别号-1548/2016。伦理批准机构-科伦坡医学研究所,斯里兰卡(编号 38/2016)。斯里兰卡临床试验注册号:SLCTR/2017/018。登记日期=2017 年 6 月 29 日。批准在临床试验中使用该设备的机构-斯里兰卡国家药品监管局(2018 年 1 月 16 日),该设备于 2016 年在日内瓦国际发明者展览会上获奖,并于 2018 年在斯里兰卡获得总统奖。它是斯里兰卡的专利设备,专利号为 SLKP/1/18295。所有方法均按照 CONSORT 2010 指南进行。

相似文献

1
Effectiveness of paranasal air suction on acute migraine using portable air sucker - a randomized, double blind study.便携式空气抽吸器经鼻旁空气抽吸治疗急性偏头痛的疗效:一项随机、双盲研究。
BMC Neurol. 2021 Apr 24;21(1):176. doi: 10.1186/s12883-021-02203-x.
2
Paranasal sinus air suction for immediate pain relief of acute migraine - a randomized, double blind pilot study.鼻窦抽吸术即刻缓解急性偏头痛疼痛的随机、双盲先导研究。
BMC Neurol. 2019 Oct 23;19(1):248. doi: 10.1186/s12883-019-1486-0.
3
Elevated nitric oxide and carbon monoxide concentration in nasal-paranasal sinus air as a diagnostic tool of migraine: a case - control study.鼻腔鼻窦空气一氧化氮和一氧化碳浓度升高作为偏头痛的诊断工具:一项病例对照研究。
BMC Neurol. 2021 Oct 26;21(1):407. doi: 10.1186/s12883-021-02434-y.
4
A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study).一项关于舒马曲坦粉末(AVP - 825)经鼻呼吸动力给药治疗急性偏头痛的随机、双盲、安慰剂对照研究(TARGET研究)。
Headache. 2015 Jan;55(1):88-100. doi: 10.1111/head.12472. Epub 2014 Oct 30.
5
Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.舒马曲坦片对自述或经医生诊断为鼻窦性头痛的偏头痛患者的疗效:一项随机、双盲、安慰剂对照研究。
Clin Ther. 2007 Jan;29(1):99-109. doi: 10.1016/j.clinthera.2007.01.012.
6
DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.DFN-02(舒马曲坦 10 毫克加渗透促进剂)鼻喷剂与安慰剂治疗偏头痛的急性发作:一项双盲、安慰剂对照研究。
Headache. 2018 May;58(5):676-687. doi: 10.1111/head.13309.
7
Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial.偏头痛发作时开始预防性治疗依普替扎umab 后偏头痛症状迅速缓解:来自随机对照 RELIEF 试验的结果。
BMC Neurol. 2022 Jun 3;22(1):205. doi: 10.1186/s12883-022-02714-1.
8
A randomized, double-blind, placebo-controlled trial on the role of preemptive analgesia with acetaminophen [paracetamol] in reducing headache following electroconvulsive therapy [ECT].一项关于对乙酰氨基酚(扑热息痛)超前镇痛在降低电休克治疗(ECT)后头痛中的作用的随机、双盲、安慰剂对照试验。
BMC Psychiatry. 2017 Jul 28;17(1):275. doi: 10.1186/s12888-017-1444-6.
9
Intravenous ibuprofen for acute treatment of migraine: A double-blind, randomized, placebo-controlled pilot study.静脉用布洛芬治疗偏头痛急性发作:一项双盲、随机、安慰剂对照的初步研究。
Headache. 2021 Oct;61(9):1432-1440. doi: 10.1111/head.14214. Epub 2021 Oct 3.
10
Efficacy of nonprescription doses of ibuprofen for treating migraine headache. a randomized controlled trial.非处方剂量布洛芬治疗偏头痛的疗效。一项随机对照试验。
Headache. 2001 Jul-Aug;41(7):665-79. doi: 10.1046/j.1526-4610.2001.041007665.x.

本文引用的文献

1
Cerebral Hemodynamic Changes During Migraine Attacks and After Triptan Treatments.偏头痛发作期间及曲坦类药物治疗后的脑血流动力学变化。
Noro Psikiyatr Ars. 2019 Feb 12;57(3):192-196. doi: 10.29399/npa.21650. eCollection 2020 Sep.
2
Paranasal sinus air suction for immediate pain relief of acute migraine - a randomized, double blind pilot study.鼻窦抽吸术即刻缓解急性偏头痛疼痛的随机、双盲先导研究。
BMC Neurol. 2019 Oct 23;19(1):248. doi: 10.1186/s12883-019-1486-0.
3
CALHM1-Mediated ATP Release and Ciliary Beat Frequency Modulation in Nasal Epithelial Cells.
CALHM1 介导热激通道开放和纤毛摆动频率调节在鼻上皮细胞中的作用。
Sci Rep. 2017 Jul 27;7(1):6687. doi: 10.1038/s41598-017-07221-9.
4
Serotonergic mechanisms in the migraine brain - a systematic review.偏头痛大脑中的5-羟色胺能机制——一项系统评价
Cephalalgia. 2017 Mar;37(3):251-264. doi: 10.1177/0333102416640501. Epub 2016 Jul 11.
5
The origin of nausea in migraine-a PET study.偏头痛中恶心的起源——一项正电子发射断层扫描研究
J Headache Pain. 2014 Dec 3;15(1):84. doi: 10.1186/1129-2377-15-84.
6
The International Classification of Headache Disorders, 3rd edition (beta version).《国际头痛疾病分类》第三版(试用版)
Cephalalgia. 2013 Jul;33(9):629-808. doi: 10.1177/0333102413485658.
7
Paranasal sinus nitric oxide and migraine: a new hypothesis on the sino rhinogenic theory.鼻窦一氧化氮与偏头痛:基于鼻-窦相关学说的新假说。
Med Hypotheses. 2013 Apr;80(4):329-40. doi: 10.1016/j.mehy.2012.12.001. Epub 2013 Feb 8.
8
Headache in a national sample of American children: prevalence and comorbidity.美国儿童全国样本中的头痛:患病率与共病情况
J Child Neurol. 2009 May;24(5):536-43. doi: 10.1177/0883073808327831.
9
Pediatric migraine.小儿偏头痛
Neurol Clin. 2009 May;27(2):481-501. doi: 10.1016/j.ncl.2008.11.003.
10
Tracheostomy suction: a protocol for practice.气管切开术吸痰:操作规范
Paediatr Nurs. 2007 Dec;19(10):14-8.